Arterium joined Congress of Ukrainian Endocrinologists’ Association
The Eighth Congress of the Ukrainian Endocrinologists’ Association was held in 20th – 22nd of October in Kyiv by the Ministry of Health of Ukraine, the National Academy of Medical Sciences of Ukraine, Association of Endocrinologists of Ukraine and Komisarenko Institute of Endocrinology and Metabolism of the Academy of Medical Sciences of Ukraine. Arterium Corporation was invited as a partner.
The Congress brought together more than 350 delegates and participants including scientists, chief endocrinologists representing regions of Ukraine, partners from CIS and non-CIS countries and practitioners.
Participants discussed current issues of fundamental and clinical endocrinology, recent innovative technologies in prevention and therapy of endocrine disorders.
The main topics of plenary and section sessions included present-day therapy of diabetes mellitus (and diabetes complications), diabetic retinopathy, diabetic nephropathy, thyroid disorders and many other issues of modern endocrinology.
At the Congress, Arterium’s Endocrinology and Biotechnological Products Team presented the Corporation to endocrinologists, its new target audience. The corporate stand also promoted our new drug Dimaryl. Dimaryl is antidiabetic tablets for non-insulin-dependent type II diabetes.
This is a brief summary of product characteristics. For full information, please refer to the patient leaflet. This website is intended for medical and pharmaceutical experts only.